Many studies have provided ample evidence suggesting the presence of aberrant signaling by the epidermal growth factor receptor (EGFR) (the ErbB tyrosine kinase receptor (TKR)), which is correlated with cancer progression [34]. Here, EGFR is linked to cancer.